Full text is available at the source.
Abstract
Obstructive sleep apnea (OSA) is highly prevalent in patients with cardiovascular disease.
- OSA may contribute to cardiovascular disease through various pathophysiological mechanisms.
- Current evidence associates OSA with increased risks of hypertension, stroke, ischemic heart disease, heart failure, atrial fibrillation, and cardiovascular mortality.
- Continuous positive airway pressure (CPAP) treatment may influence cardiovascular risk factors and outcomes.
- Obesity is emphasized as a significant comorbidity of OSA and may confound its association with cardiovascular disease.
- Addressing obesity in patients with OSA could be a strategy to reduce cardiovascular risk factors.
Simplified